Comments on: FDA accepts BioArctic’s partner Eisai’s BLA for subcutaneous maintenance dosing of Leqembi in the US

Comments on: FDA accepts BioArctic’s partner Eisai’s BLA for subcutaneous maintenance dosing of Leqembi in the US https://nordiclifescience.org/fda-accepts-bioarctics-partner-eisais-bla-for-subcutaneous-maintenance-dosing-of-leqembi-in-the-us/ Tue, 14 Jan 2025 08:02:00 +0000 hourly 1 https://wordpress.org/?v=6.7.1